December 31, 2008

Mindray Medical: Quick Note

The Fool owns shares of Mindray Medical. It is also a Rule Breaker.

Two Agree on 3SBIO

3SBIO (SSRX) is a Chineese BioTech company that has been pegged as undervalued and in store for high growth. In this article, the Fool has dubbed shares of the company cheap, especially compared to other stocks in the industry.

In this article, Zacks also likes the growth prospects of the company and have given a price target of $10 over the next 6 to 12 months.

GrafTech International: Value Play

GrafTech International was featured in an article by the Fool, where they note that they own shares of the stock. This is a steel company that appears to be significantly undervalued. Its current P/E is under 5, forward P/E is under 4, and its PEG ratio is .32.

December 30, 2008

Exelixis: A Top Health Care Pick

The Stock Masters mentions Exelixis as one of their six top health care picks. They mention that the company has "broad programs which are highly partnerable."

December 22, 2008

The Fool Ownes Shares Of

I stumbled across this site that lists all stocks that the Fool has disclosed that it owns shares of as of 11/17/08.

A Look At Two Rule Breakers

The Fool mentions two of its Rule Breakers in one article today: Interactive Intelligence and Dawson Geophysical.

The Fool owns shares of Dawson and it is trading near its 52 week low, which translates into a P/E of slightly above 3 and a forward P/E of just under 5.

One note of caution: this company's services are tied to the oil industry. With the market down on oil prospects, this could continue to affect Dawson's stock price.

December 18, 2008

Somanetics: Hidden Gem

The Fool is running a series of articles today where they examine a few stocks that they have pegged as candidates for the "Best Stock for 2009." One stock that they examine is a company named Somanetics.

This company has been selected twice as a MF Hidden Gem. The company is primarily known for making medical devices that monitor oxygen saturation in the brain.

The article notes that according to the author's DCF analysis, the company should trade for $24 instead of $17. They also remark that they could see this company being bought in the future by a larger medical device maker.

December 16, 2008

Sun Hydraulics: A Hidden Gem

The Fool has a small article on Sun Hydraulics, a small company that manufactures hydraulic components for heavy machinery. They note that the company has seen its shares drop more than 60% this year, but they anticipate many years of growth for the company.

A similar feeling is echoed in this article that mentions Charles Allmon and his growth stock strategy. He look at sales growth first, EPS second, and balance sheet third. One of his most recent picks was Sun Hydraulics.

Ebix: A Rule Breaker

The Motley Fool mentions one of their Rule Breaker picks briefly in this article. Ebix is a company that makes software that is used to track and issue insurance certificates.

The company just bought one of their competitors, Confirmnet which should improve business prospects. This company should definitely go on your watch list, but you may want to wait until the company reports earnings for this current quarter. There may be cost associated with the buyout of Confirmnet that eat into EPS.

December 11, 2008

Hurco: Down But Not Out

The Fool notes that Hurco, one of their Hidden Gems picks reported today that net income for the fourth quarter declined 40% as orders fell. As a result, the stock is down 16% as I write.

The Fool points out that the company doesn't appear to be going away any time soon as they have $33 million in cash and no debt. The reason that emerging economies like India and China will need Hurco's technology when they recover.

December 9, 2008

The Next BioTech Buyout?

Seeking Alpha has an article on two potential buyout candidates: Allergan and Medicis, with the author leaning more towards Allergan as the company that is likely to be bought. Pfizer has been rumored to buy both companies.

With the recent price decline in these stocks, it may make sense to buy a stake in each of them and wait for them to recover, while awaiting any substantial buyout news.

December 4, 2008

The Stockmasters points out that Evergreen Solar (like many stocks) is sitting close to a 52 week low. They also note that the company has recently signed two contracts worth over $160 million. They also speculate that the company will profit under the Obama administration as they will more likely advocate greener sources of energy.

December 2, 2008

What do Autozone, Autonation, and Sears Auto Have in Common

The answer is Eddie Lampert has at least a 50% ownership in all three companies. Value Investor Todd Sullivan pointed this out in a recent article. He believes that it is only a matter of time before we find out what will happen between the three companies.

$16 Price Target on ViroPharma

Zacks is out with a $16 price target on ViroPharma, siting strong Vancocin sales and strong future sales of Cinryze.